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BARRIERS TO COMBATING INFECTIOUS DISEASE 
GLOBALLY: A LOOK AT DENGUE FEVER 
Rob J. Fernandez 
T he University of Iowa 
Infectious disease remains one of the most important concerns in global health . 
Serious infectious diseases affect hundreds of millions of people worldwide each year. 
While attention is often focused on HIV/ AIDS, malaria or TB, dengue fever and its 
more lethal variety dengue hemorrhagic fever (DHF) are also a risk for the more than 2.5 
billion people living in tropical and sub-tropical regions across the globe, according to 
the World Health Organization (WHO ). Approximately 50 million cases, about 400,000 
of which are DHF, are documented each year, with some countries reporting it as a lead -
ing cause of child mortality ( 1 ). Although overall case fata li ty rates have been decreasing 
slightly, there have been significant dengue outbreaks in recent years spanning a broad 
swath of the globe (2, 3 & 4 ). The majority of people who are at risk tend to reside in 
poor, developing countries. It is these very countries tl1at experience the most difficulty 
in effectively combating any infectious disease. This difficulty arises primarily as a result 
of the intense poverty that plagues much of the developing world. Endless nation-spe-
cific, yet interrelated reasons exist. The scope of all the impediments to effective dengue 
control would be too broad and complicated to cover in a single commentary. Instead , 
the paper focuses on several barriers tliat are common to most countries facing problems 
associated with infectious disease, especially dengue fever. The overarching point is that 
no matter what prevents a country or a people from fighting the disease, it will almost 
always be associated with, or reduced to, financial means ( or lack thereof). 
D ENGUE O VERVIEW 
Dengue fever (DF ) and dengue hemorrhagic fever (DHF) are spread by mosquitoes, 
specifically the Aedes aegypti breed. This same mosquito has been responsible for trans-
mitting yellow fever in decades past. Four independent viral strains of dengue have been 
detected, DEN-1, DEN-2, DEN-3 and DEN-4 (5, 6 ). The initial, non -specific and self-
limited presenting signs and symptoms of someone who may have contracted dengue 
resemble the flu, with exceptionally painful body aches leading to the designation: 
"bone-break fever." At times it is thought to mimic malaria with high fevers and severe 
headaches. Subsequent re -infections or new infections with different strains can lead to 
DHF, which is life-threatening witli up to a 50 percent case fatality rate if left untreated 
( 1 ). Symptoms of DHF include hemorrhaging from the skin, severe dehydration, low 
blood pressure, and in some cases shock, also referred to as dengue shock syndrome 
(DSS ) (5, 6 ). Treatment is basic life-support consisting of addressing the symptoms as 
tl1ey occur. Typically it requires re-hydration, bed-rest, and close monitoring of the 
patient to assure the condition does not worsen. 
Unfortunately, many people are unaware of the severity of dengue, th us they do not 
seek or cannot seek treatment. Some die quickly, in a matter of days, from one of the 
more deadly forms of the disease . Many methods of assessing and responding to the bur-
den of infectious disease in targeted populations continue to be of urgent interest. Yet 
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social, political, cultural and environmental barriers consistently prevent effective control 
of dengue as well as other infectious diseases. Several of these barriers overlap and are 
reviewed here . 
SOCIAL BAIUUERS 
One obvious solution to dengue would be to exterminate the vector, and many cam-
paigns strive to eliminate the mosquitoes or significantly reduce their numbers. Often, 
countries endemic with dengue have attempted community education campaigns to help 
eliminate the mosquitoes. These campaigns strive to get members of a community active-
ly involved in avoiding infection through teaching them about disease transmission. In 
the case of dengue education campaigns, discussion focused on the mosquitoes that 
transmit the virus. Since mosquitoes breed in areas of standing water, it makes sense to 
try to dry up swamps and ditches, use lids on water containers and properly dispose of 
waste that can accumulate water (i.e ., old vehicle tires). Yet, campaigns aimed at benefit-
ing the community and protecting people or residents and community members from 
future outbreaks raise their own issues. Obviously, drying up swamps, for example, not 
only rids the area of mosquitoes, but of all other natural wildlife that coexisted in the 
swamp habitat. Increased urbanization and crowding in developing countries also affects 
how waste is disposed. Sometimes improper planning or insufficient space forces a nation 
to deposit mosquito and rodent attracting waste near densely populated communities, 
which are often impoverished and at high risk of disease from many factors (7 ). Other 
times insufficient funding for these educational programs is to blame. Therefore, many 
programs are discontinued before accomplishing their long-range goals . The intended 
educational agenda cannot be productive and effective if it is only offered for a brief peri -
od of time. To have any major impact, the campaign needs to be sustained for several 
years, if not permanently. Several educational campaigns in the past have shown a high 
degree of effectiveness with handling dengue. For instance, in the 1980s, Cuba initiated 
an educational campaign focusing on increased community awareness of dengue and its 
vector following an outbreak (8). Active participation of the Cuban citizens allowed for 
the vector to be virtually eliminated . This campaign was successful primarily due to its 
long-term commitment to the members of the community years after the initial epidem-
ic. 
Another method is the use of the pesticide chemical DDT ( dichlorodiphenyl-
trichloroethane ), which kills the insect (7). Topical spraying of DDT has been effective 
at controlling disease vectors in the past, but it is often as much a barrier as it is a solu-
tion. The carcinogenic, disease-inducing component of the chemical creates its own 
health risks, a reason its use has been discontinued in the United States and elsewhere. 
But the question that is often raised is whether the people most at risk are more likely to 
fall ill to an infection resulting in dengue, for instance, or to die from cancer? There is no 
easy solution. Chemicals like DDT remain in the environment for years after they are 
released, but millions of people are suffering or are at risk now. Moderate and controlled 
DDT use could be a compromise for regions frequently faced with attacks of the dengue 
virus. Of course many of the decisions regarding the fight against dengue and other 
threats reside in the hands of the local governments of these countries. 
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POLITICAL BARRIERS 
Disease surveillance, infection documentation and public access to care are all 
extremely important to help monitor disease trends, predict epidemics and deliver med -
ical treatment to those in need of it. Yet subtle political barriers may prevent accurate 
reporting. The reasons may be considered in the nation's best political or economic inter-
est, especially in cases where a country's only major industry is tourism. There may be 
concerns about attracting foreign visitors. If every single case of dengue is reported to a 
disease surveillance database, which is then published where tourists can access it, vaca-
tioners may form unfavorable opinions about traveling to endemic regions. Politicians 
may worry that tourists could stop visiting the country for fear of becoming infected with 
this tropical virus. While it is considered outrageous and unethical that there might be 
"intentional" errors in reporting or official documentation of disease cases, it is not illog-
ical when considered from an economical or political standpoint. The Centers for Disease 
Control and Prevention (CDC ) have noted that underreporting disease information with 
regards to the Global AIDS Program (GAP ) in India is a continual challenge to over-
come (9 ). Similarly, the WHO makes reference to possible weaknesses in data on cholera 
due to underreporting. They mention that underreporting of disease is quite common in 
many countries for fear of loss of tourism revenue as well as poor surveillance methods 
(10). 
Intentional underreporting of disease cases in order to maintain an idealized image 
would be difficult to substantiate. However, when developing nations lack the proper 
staffing and the financial means to support an efficacious system of surveillance and epi-
demiological research, such omissions of data whether intentional or unintentional are 
likely. Without accurate incidence data on dengue, public health agencies are unable to 
adequately plan for epidemics, manage endemic regions or precisely target areas in imme-
diate need of medical or environmental attention . 
Finally, access to care is, and probably will be for years to come, a significant barrier. 
If there is no data to support a need for more targeted care, medical clinics and/ or 
increased staffing based on the burden of unmet care for dengue sufferers, there will like-
ly be none despite actual need. Indeed, while some bench research is being done, the rel -
evant public health focused research is very limited, which raises another controversial 
barrier: research, ethics and cultural sensitivity. 
C ULTURAL OR E THICAL BARRI ERS 
The cultural content of public health programming is important because much of the 
information that is gathered concerning infectious disease is based upon research within 
populations of developing countries. Currently, live attenuated vaccines against the 
dengue viral strains are in clinical trials, and further research in the area relating to alter-
native vaccine options is swiftly underway ( 11 ). Vaccines historically have been one of the 
most effective methods for wide-scale infectious disease control. The economic advan -
tages of cost savings by preventing disease provide a partial explanation for vaccine suc-
cess . However, vaccine trials raise many ethical questions. For instance, how, where and 
why clinical trials and other research (including vaccine implementation ) is decided and 
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conducted to advance scientific knowledge? 
Consider a poverty stricken section of a population at risk for a particular infectio us 
disease like dengue. Technically, research commences with consent of the individuals 
involved . " Info rmed consent" invo lves clarifying the advantages, disadvantages, risks, 
side effects, etc. for the research participant thoroughly before the study can begin . In 
some circumstances, this ri ght of the individual may be abused if, fo r example , a sizable 
proportio n of this same "at risk" population is illiterate o r unable to fully appreciate or 
comprehend the reasons fo r the research. Majo r differences may exist between satisfying 
a third world nation 's healthcare needs versus those of mo re developed nations. In this 
circumstance, it is easy to imagine stretching the co ncept of "informed consent" to bare-
ly mean "consent" in general, if at all. 
T hese essential ethical q uestio ns require continual testing and discussion throughout 
medical academia, especially glo bal health ( 12, 13 ). Research cannot be justified that is 
not culturall y sensitive, or that takes advantage of a vulnerable population. Some public 
health workers argue that what is needed in these countries is not new research, but more 
foc us o n primary care to treat those suffering from infectious disease now. Regrettably, 
there is again a fin ancial component to this argument. Research can mean more mo ney 
to public health researchers; more money can mean more research. It is important that 
basic scientific knowledge of infectio us disease is advanced , however, it is equally impor-
tant that this objective is balanced wi th the correspondingly imperative need of diagnos-
ing, treati ng and caring fo r people suffering fro m those very diseases worldwide. 
Unfortunately, the numbers and distribution of medical practitio ners, nurses and other 
healthcare providers per citizen o f impoverished countries, is much lower than it needs 
to be for basic healthcare. T his cannot become mo re obvio us than when a nation is chal-
lenged by environmental turmoil. 
ENVIRO MENTAL BAIUUERS 
T hese are impo rtant barriers to consider since it is o ne over which individuals have 
little control. Natural disasters have enormo us adverse effects o n developing nations. 
Climate changes alo ne can disrupt the environment and affect vector populatio ns, which 
in turn affect in fectio n rates o f dengue (7). Financially disadvantaged countries suffer 
fro m the everyday battle of controlling endemic disease within their populations. When 
natural disasters occur, they not o nly disrupt the environment, but also increase risk for 
many infections - especially water-bo rne and vector-borne infectio ns. 
Recently, we learned of the public health tragedy that foll owed in the wake of the 
Indian Ocean tsunami . T his event affected millions of people, with deaths reaching well 
over 150,000, according to several media reports including CNN ( 14 ). The true tragedy 
caused by this tsunami occurred fo r entire natio ns and individuals in the months after-
wards. According to the World H ealth Organization, in the aftermath of the tsunami , 
people were at an increased ri sk of contracting infectious diseases such as malaria and 
dengue ( 15 ), due to disruptio n of the environment, which created an increase in vector 
populations fro m standing water. Human populations in these regions now face more 
risk of disease after suffering the detrimental effects of the tsunami itsel f. The tsunami 
clearly illustrates how natural events create barriers to public healthcare , leaving nations 
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in shambles, and populations increasingly vulnerable to disease . What is even more dis-
concerting is that nations suffering from natural disasters often lose more vital financial 
resources, rearranging national priorities and further debilitating the effective delivery of 
medical care. 
REMOVING THE BARJU ER.S 
These examples illustrate only a small piece of the complex puzzle facing infectious 
disease globally. Social, political, cultural and environmental barriers will continue to 
challenge populations most vulnerable to infectious diseases, such as dengue . Economic 
constraints will probably always complicate these obstacles. Without financial means, 
developing nations are left with limited options to providing care to their populations. 
There is no single, concrete solution, but there is the hope of improvement in the future . 
If enough people become aware of the various barriers, steps can be taken individually 
and globally to create a shift in the current state. 
The single most important step will require that people most at risk for infectious 
disease become familiar with why they are at risk, how to decrease that risk, and prevent 
future infection . Education initiatives alone may be ineffective . Rather, interventions 
concentrating on educating individuals on infectious disease transmission, as well as 
insisting upon and monitoring active adjustments in daily routine and behavior, may 
indeed provide positive, lasting results. People residing in high -risk locales must become 
familiar with disease vectors in their area, how to avoid infection, and what to do in the 
event they develop symptoms. Simple precautions can be taken to avoid infection with 
the dengue virus . Citizens at risk should avoid traveling near standing water or swamp-
lands without proper clothing and mosquito repellant. Over night, residents can further 
add protection to their homes through the use of bed-nets . Containers meant to store 
water need to have lids on them to prevent mosquitoes from laying their eggs. 
The key to preventing infection is to limit exposure to the transmitting vector. Yet, 
although people in these regions can actively decrease their risk, it is the responsibility of 
government and public health officials to initiate appropriate interventions, and maintain 
them for their citizens. Effort needs to be put forth by public health agencies to consis-
tently keep accurate surveillance data, with continual updates of endemic regions. The 
reporting of disease rates must improve, as well as campaigns aimed at large-scale vector 
reduction . Outreach clinics are increasingly necessary in order to provide immediate care 
in remote locations. The entire order of operations in regards to public health response 
in developing countries should be continually re -evaluated and improved . Of course, as 
is ever so obvious, almost none of these important objectives can ever be effectively met 
without an economic and political drive. Even then, if the movement is present through-
out a government or public health agency to initiate change, little can be accomplished 
with an insufficient budget. 
It is unfortunate that the healtl1 of millions must be reduced to financial availability. 
However, this situation is unlikely to change and may become increasingly complicated. 
Thus, as much as it is the responsibility of public health and government officials to 
inform and protect people who are at risk, it is just as much everyone's responsibility to 
realize that very little can be done without financial support. Taken together, increased 
10 International Journal of Global H ealth and Health Disparities 
5
Fernandez: Barriers to Combating Infectious Disease Globally: A Look at Deng
Published by UNI ScholarWorks, 2005
awareness could help faci litate fundin g through philanthropic contributions to countries 
most at risk and in need of assistance. Once the ball is rolling, public health agencies can 
perfect their po licies and procedures for assessing the infectious diseases most threaten-
ing to their populations. This shall be no simple task, yet the need to shed attention on 
dengue and related challenges is ever present and always evolving. 
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